CORRECTION: ProMIS Neurosciences Announces First Quarter

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) -- There was an error at the end of the first paragraph. March 31, 2021 has...

Related Keywords

United States ,United Kingdom ,Massachusetts ,Saskatchewan ,Manitoba ,Canada ,Montreal ,Quebec ,Cambridge ,Cambridgeshire ,Toronto ,Ontario ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,American ,British ,Larry Altstiel ,Carsten Korth ,Alain Dagher ,Neil Cashman ,Gene Williams ,David Wishart ,Larry Altsteil ,Guy Rouleau ,Justin Yerbury ,Michelle Hastings ,University Of Saskatchewan Vaccine ,Department Of Neurology ,Promis Neurosciences Inc ,Good Laboratory Practice ,Tanenbaum Open Science Institute ,Neurosurgery Of Mcgill University ,Pfizer ,University Of California San Diego ,University Of British Columbia ,Infectious Disease Organization ,Laboratory Medicine ,American Academy Of Neurology ,Neuro Montreal Neurological Institute ,Chief Medical Officer ,Potential Next Generation Therapy ,Good Manufacturing Practice ,British Columbia ,Gene Yeo ,California San Diego ,American Academy ,Associated Global Translational Suppression ,Saskatchewan Vaccine ,Chief Physics Officer ,Scientific Advisory ,Molecular Neuropathology ,Cheryl Wellington ,Montreal Neurological Institute Hospital ,Mcgill University ,Mcgill University Health Centre ,Tanenbaum Open Science ,Montreal Neurological ,Chief Medical ,Toronto Stock Exchange Pmn ,Romis Neurosciences Inc ,